what is the difference of semaglutide and tirzepatide Comparative safety side effects and tirzepatide: Implications for clinical decision-making in obesity management Tirzepatide vs semaglutide for weight

As a class of medications that function as GLP-1 agonists, theyre showing incredible promise, boasting an average weight loss of 15 to 20 percent

Approximately half of all patients who begin taking these drugs discontinue their use within the first year, however, and three-quarters have stopped after two years

No unexpected safety issues have arisen to date, and the established safety profile for semaglutide is similar to that of other GLP-1RAs where definitive conclusions for pancreatic and thyroid cancer cannot be drawn at this point due to low incidence of these conditions

It is also employed for diabetic patients who already have cardiovascular disease, to help reduce the risk of major cardiovascular events such as stroke or heart attack